IP Library Granted Patent US 10,668,099
Granted Patent B2
US 10,668,099 · App. 16/113,331 · Granted Jun 2, 2020

Methods and compositions for treating conditions associated with infection and/or inflammation

Inventors: Keith Goldan (Fort Worth, TX); Claire Sampson (Fort Worth, TX)
Assignee: URGO US, INC.
A61K33/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,668,099
App. No.
16/113,331
Granted
Jun 2, 2020
Kind
B2
Abstract

The present invention provides methods and compositions for treating and preventing conditions characterized by infection and/or inflammation, especially of the eyes, ears, nose, and/or throat. The methods of the invention involve administering hypohalous acid to the patient, such as in the form of a composition described herein.

Claims (21)

1. A method for treating an ocular condition characterized by a bacterial infection and chronic inflammation of an eye of a subject, comprising: administering to the eye of a subject an effective amount of a hypochlorous acid solution, wherein the hypochlorous acid has an available free chlorine content of at least 250 ppm, and is at least 80% hypochlorous acid relative to the total amount of hypochlorous acid, hypochlorite, and Cl 2 as 100%.

2. The method of claim 1 , wherein the ocular condition includes conjunctivitis, blepharitis, external hordeolum, internal hordeolum, uveitis, canaliculitis, and/or dacrocystitis.

3. The method of claim 1 , wherein the bacterial infection involves Staphylococci and/or Streptococci, optionally including methicillin-resistant Staphylococcus aureus.

4. The method of claim 1 , wherein the bacterial infection is antibiotic resistant.

5. The method of claim 4 , wherein the bacterial infection is resistant to a beta-lactam or fluoroquinilone antibiotic.

6. The method of claim 1 , wherein the infection is a superinfection of viral and bacterial etiologies.

7. The method of claim 1 , wherein the bacterial infection produces a discharge or wherein the bacterial infection is an acute infection secondary to the chronic inflammation.

8. The method of claim 1 , wherein the condition is recurring.

9. The method of claim 1 , wherein the treatment reduces the capacity of the infection to spread.

10. The method of claim 7 , wherein the hypochlorous acid is administered:

instead of anti-inflammatory medication and/or antibiotics.

11. The method of claim 1 , wherein the condition additionally comprises a viral infection.

12. The method of claim 1 , wherein the hypochlorous acid has a pH of from 4 to 7.

13. The method of claim 1 , wherein the hypochlorous acid has an available free chlorine content of above from 250 ppm to 400 ppm.

14. The method of claim 1 , wherein the available free chlorine consists essentially of hypochlorous acid as an active agent.

15. The method of claim 1 , wherein the hypochlorous acid solution has from 250 to 600 ppm AFC.

16. The method of claim 15 , wherein the condition involves bacterial conjunctivitis.

17. The method of claim 16 , wherein the solution is administered as an eye drop or eye wash.

18. The method of claim 17 , wherein the solution is administered from 1 to 4 times per day.

19. The method of claim 1 , wherein the ocular condition includes allergic conjunctivitis.

20. The method of claim 1 , wherein the ocular condition includes uveitis.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2020
From: GOLDAN, KEITH; SAMPSON, CLAIRE
To: PURICORE, INC.
Reel/Frame 051467/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2019
From: REALM THERAPEUTICS, INC.
To: URGO US, INC.
Reel/Frame 049405/0191 →
CHANGE OF NAME Recorded Jan 31, 2019
From: PURICORE, INC.
To: REALM THERAPEUTICS, INC.
Reel/Frame 048204/0629 →